Therefore, up-regulation of the actin cytoskeleton/RhoA regulation pathway may increase platinum drug sensitivity and improve prognosis by inhibiting EMT, reducing metastasis and regulating the number of cancer stem cells (Li et al., 2019). The gene discussed is RHOA; the disease is cancer.